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"Was man nicht hat, das eben braucht man; 
und was man hat, das könnt' noch besser werden" 
naar Goethe 
θ 
INTRODUCTION 
There can be little doubt, that 2-naphthol incorporated in a so-called 
"peeling paste", is the most effective peeling agent currently available 
It has been a major contribution to the management of persistant acne 
vulgaris since 1881 
Yet, we must accept the fact that this drug has been shown to have a 
potential for harm It may be associated with formidable side effects, 
which are well known by the practioner Through skill gained from 
experience it has been possible to effectively manage most patients 
while avoiding serious complications 
Frequently, the question arises regarding how much drug on what 
surface area can be safely applied An unequivocal answer is not yet 
possible As far as reliable information about absorption rate, distri-
bution and metabolic fate of dermatotherapeutics is concerned, we 
have made little more than a beginning 
The following chapters will deal with some of these problems 
Chapter I, gives a short survey of the penetration through skin No 
attempt has been made to review the literature exhaustively There 
have been many reviews m recent years, the most complete of them 
are given as references in this chapter 
Chapter II, describes a rapid procedure for determining 2-naphthol and 
its metabolites m plasma and urine Plasma levels and urinary excretion 
data for the drug are reported from patients treated with the peeling 
paste 
Chapter III, reports the results of pharmacokinetic investigations on 
2-naphthol in dogs Plasma levels and urinary excretion of the drug and 
its conjugates following a constant rate of intravenous infusion are 
given 
Chapter IV, deals with the systemic absorption of 2-naphthol, measured 
as a function of time, drug concentration and ointment composition 
after application of the compound to the flanks of a dog 
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CHAPTER I 
PERCUTANEOUS ABSORPTION 
The development of an effective integument was a requirement forced 
upon nature by the emergence of life from the sea. Hence, the principal 
functions of the skin are to protect the body from physical and chemical 
insults and to help to maintain its internal environment. Therefore, it is 
designed to impede absorption. 
Absorption is a dynamic process going on more or less simultaneously 
with a lot of other processes and cannot be considered in isolation. 
The epidermis is composed of cells in four stages of development 
before they are, finally, shed and replaced 
It is taken for granted that the barrier is located in the keratinized 
cells of the stratum corneum, because the skin becomes increasingly 
permeable if successive layers are stripped by adhesive tape. Most 
water soluble, low molecular weight, non-electrolytes applied to the 
skin surface diffuse into the inner milieu approximately a thousand 
times more rapidly when the horny layer is diseased, damaged or 
removed. 
In discussing percutaneous absorption it is necessary to consider the 
skin itself, as well as the drug and the vehicle m which the drug is 
presented to the skin surface 
There are several possible routes for penetration through the skin; 
through the cells of the stratum corneum, through the hair follicles or 
sebaceous glands and through the sweat ducts. The contribution of 
the skin appendages to skin permeability is, usually, minimal owing to 
their relatively small total fractional area - approximately 1:1000 -. 
Theoretical considerations and some experimental results indicate that 
these shunt pathways can, however, be very significant during the first 
phase of the penetration for molecules that penetrate the stratum 
corneum slowly. 
The literature on the influence of vehicles on skin penetration is con-
fusing and often contradictory. Many skin applications have ordinary 
but complex vehicles included, e.g. emolients, emulsifiers, thickeners 
preservatives, substances to improve acceptability or stability. Such 
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Fig. 1-1. The stratified organization of the skin. The top layer, the epidermis, is thin but 
solidly cellular, in contrast to the much thicker and largely fibrous dermis which acts 
mainly as a support for the appendages, vessels and nerves. 1. Stratum corneum 
2. Sebacecous gland, 3. Hair, 4. Eccrine gland. 
substances sometimes interfere with efficacy by reducing the physio-
logical availability of the active principle. The drug incorporated in the 
vehicle should be present in sufficient amount and reach the skin 
surface at an adequate rate. When the compound is insoluble, absorp-
tion is enhanced by reduction of particle size. In an emulsion, only the 
drug dissolved in the external phase is immediately available for 
diffusion. 
The release of a drug is favoured by vehicles having a low affinity for 
the penetrant. The partition coefficient of the drug (and consequently 
12 
its thermodynamic activity) in the vehicle in relation to the skin, may 
vary as much as a thousandfold from one vehicle to another for iden-
tical concentrations Low partition coefficients are obtained when 
solutes are held firmly by the vehicle, for example m the cases where 
the drug forms soluble complexes with the vehicle The rate of release 
from such drug-vehicle combinations is slow, as was shown by 
Scheuplem and Blank m a study of the penetration of polar ethanol 
and nonpolar heptanol from water and lipid solvents In order to 
obtain maximum release rates each compound requires individual for-
mulation based on solubility characteristics 
It has often been stated that the addition of certain compounds may 
increase the absorption rate of drugs In many cases the acceleration 
is obtained by changing the polarity of the solvent or the vehicle in 
which the drug is incorporated 
The acceleration may also be obtained by lowering the surface tension, 
which results m a better contact between the drug and the skin This 
surface tension lowering effect may promote the trans-appendage 
absorption Often the integrity of the skin barrier is affected more or 
less temporarily, for example by the dressing, by salicylic acid, some 
surface active agents, dimethylsulfoxide, etc 
The absorption of a drug from a topically applied vehicle can be con-
sidered in two phases, primarily the drug penetrates from the surface 
of the skin into the living epidermal and dermal tissues and then secon-
darily into the circulatory system of the body Absorption in each of 
these two phases is referred to more specifically as "intracutaneous" 
absorption and "systemic" absorption respectively The degree of 
absorption in each of these phases can be varied dependent on the 
reason for initiating percutaneous absorption Generally, localized 
dermal therapy is desired and therefore an adequate amount of drug 
is intended to be concentrated m the intracutaneous phase at the 
specific site Subsequent systemic absorption should preferably be 
kept to a minimum in order to prolong the contact of the drug with the 
skin tissues and to reduce an eventual activity of the drug in causing 
undesirable systemic side-effects This is of particular relevance for 
potent dermatotherapeutics, e g phenols, corticosteroids 
Quantitative data for the systemic absorption of these drugs are 
especially interesting for clinical management when these substances 
are applied to diseased or damaged skin, because under these circum-
stances the percutaneous absorption easily reaches a maximum, and 
moreover other influences may interfere 
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Fig 1-2 Penetration of 2-naphthol through dog skin 
Figure 1-2 shows a typical curve for penetration of a non-electrolyte 
through the skin as a function of time. 
Diffusion is virtually a passive physical process. The rates of absorp­
tion are determined by the physico-chemical proporties of the absor­
bent and the membrane and by the concentration gradient of the 
absorbent through the membrane. The rate of absorption is given by 
Pick's general law of diffusion: 
At 
— Js — KpACs 
where Q is the amount of the penetrant; A is the area of the membrane; 
t is the time; Js is the flux or the amount which penetrates per unit area 
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and per unit time, Kp is the permeability constant, and ACS IS the 
difference in concentration of the absorbent between both sides of the 
membrane 
The amount of substance penetrating the skin plotted against time 
gives a straight line as soon as a steady penetration rate has been 
reached After the lag period the slope of this line is dependent on 
the concentration of the drug in the vehicle and the permeability of the 
membrane Consequently the plasma level curve of the drug after the 
lag time mimics a constant rate intravenous infusion 
From a clinical point of view, in many instances, not only the total 
amount of drug reaching the systemic circulation is an important 
criterium but even more so is the rate at which the drug reaches the 
systemic circulation For the body level of the drug must be kept below 
the maximum level which might produce undesired effects and toxicity 
Since it is technologically mfeasible to monitor the loss of drug from 
the skin to the absorption site, the rate of absorption derived from the 
drug's appearance m the equilibrated fluids of distribution of the body 
is a proper criterium for the rate of systemic absorption Now we are 
faced with a composite of two related research problems We must 
develop a highly sensitive and reasonably rapid analytical method for 
the determination of the drug and its metabolites m blood, urine and 
feces The development of this assay method will allow us to attack 
the second problem - the determination of the pharmacokinetic profile 
for the drug in an in vivo situation Determination of the pharmaco­
kinetics following a constant rate intravenous infusion of the drug 
allows an appraisal of the penetration rate of the drug and an evalua­
tion of the biological availability of the drug from different vehicles 
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CHAPTER II 
PERCUTANEOUS ABSORPTION 
AND DISTRIBUTION OF 2-NAPHTHOL IN MAN 
SUMMARY 
A procedure is described for determining unchanged ("free") and 
conjugated 2-naphthol in plasma and urine The method, based on gas 
chromatography, is rapid and has a limit of detection of approximately 
2 μg/m\ 
The cutaneous barriers were found to be easily traversed by 2-naphthol 
Plasma levels of 2-naphthol and conjugated 2-naphthol during and 
after topical treatment with a 2-naphthol containing peeling paste were 
measured m four patients Plasma levels of "free" 2-naphthol were 
significantly lower than the plasma levels of conjugated 2-naphthol 
24 Hours urine excretion data of 2-naphthol following therapeutic ap­
plication of 2-naphthol containing ointment on the skin of ten patients 
are reported 
The relevance of the data for clinical practice is discussed 
INTRODUCTION 
2-Naphthol (usually called beta naphthol) is a powerful dermato-
therapeutic agent, which has been extensively used since its introduc­
tion by Ludwig and Kaposi in 1881 Before the advent of modern 
anthelmintics, 2-naphthol was also used as a vermicide, for which 
purpose it proved to have little therapeutic value because of its 
toxicity (Smilhe, 1920) The effectiveness of 2-naphthol in peeling 
pastes for the treatment of persitant acne vulgaris has kept this drug 
m the current Pharmacopoeia's, although with restrictions as to its 
dosage (Volk and Winter, 1936, Percival, 1967; Powell, 1970) 
The contents of this chapter will be published in Br J Derm 87 (1972) 
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In contrast to the large amount of data about side effects (Anon , 1922, 
Osol and Farrar, 1947, Albignente, 1968, Clarke 1969, Gleason, 
Gosselm, Hodge and Smith, 1969) there has been relatively little repor-
ted on the biochemical and pharmacological levels (Harkness and 
Beveridge 1966, Powell, 1970) 
Administered to animals, 2-naphthol is excreted as a conjugate of 
glucuronic acid, as free 2-naphthol and to a minor extent as a conjugate 
of sulphuric acid (Lesmk and Nencki, 1886, Berenbom and Young, 1951, 
Boyland and Wiltshire 1953, Corner and Young, 1954, 1955) 
metabolism of 2-naphthol 
This chapter will, therefore, deal with the development of a sensitive 
and rapid analytical method for the determination of 2-naphthol and 
its conjugates in plasma and urine 
MATERIALS AND METHODS 
Reagents and drugs 
All reagents used were analytical grade (Merck), the drugs used were 
Dutch Pharmacopoeia, Edition VII, grade 
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Apparatus 
A Hewlett Packard model F & M 402 high efficiency gas Chromatograph, 
with a flame ionisation detector and a Hewlett Packard Moseley recor­
der model 7127 A, was used 
The gas Chromatograph was operated under the following conditions: 
U-shaped glass column (length 180 cm, inner diameter 0 3 cm) packed 
with 3 8%-UCW-98 on 80/100 mesh Chromosorb W (Dimethyldichloro-
silane, high performance), nitrogen gas flow 50 ml/mm, air flow 600 
ml/mm; hydrogen flow 50 ml/mm, column temperature 160° C; in­
jection port, flash heater and detector temperature 190° С 
Extraction procedure 
a The unchanged (free) 2-naphthol 
Five ml urine or 2 0 ml plasma was acidified with 1 ml IN hydro­
chloric acid and immediately thereafter extracted three times with 
15 ml peroxide-free ether m a 40 ml glass-stoppered tube by 
shaking on an automatic shaker for 10 minutes. The ether extracts 
were dried with dehydrated sodium sulphate and evaporated to 
dryness m a 25° С water bath under nitrogen 
b The total of free and conjugated 2-naphthol 
Five ml urine or 2 0 ml plasma was acidified with 1 ml concentrated 
hydrochloric acid and the glass-stoppered tubes immersed m a 
waterbath at 70° С for 4 hours (Bakke and Schelme, 1969) The 
2-naphthol was extracted as described above 
Determination 
The residue from the ether extraction was dissolved in ethyl acetate 
(between 0 10 and 5 00 ml, dependent on the concentration to be 
expected) and 3 microliter of this solution was injected into the gas 
Chromatograph The height of the 2-naphthol peak on the chromato-
gram (for an example see figure 11-1) compared with chromatograms 
obtained from known amounts of 2-naphthol was used as a measure 
of the amount of 2-naphthol in the sample Each extraction sample was 
run three times An average of the three determinations was taken. 
The sensitivity of the instrument was checked each hour with 2-naphthol 
19 
standard solutions at known concentrations Anthracene can be used 
as an internal standard 
Patients and treatment 
The subjects studied were hospitalized patients, aged from 18-22 
years, under treatment for gross acne vulgaris, involving face, neck 
and trunk in various degrees The subjects were free of clinically 
demonstrable hepatic and renal diseases 
The so called peeling paste applied, contained 20% 2-naphthol, 20% 
soft soap, 10% precipitated sulphur and 50% soft paraffin 7 5 gram 
of the ointment was applied daily to about 300 cm2 of the skin with a 
wooden spatula, thereafter covered with bandages and left on the skin 
for approximately seven hours The applications were repeated daily 
until marked desquamation with inflammation resulted in removal of 
comedones and suppression of the acne 
Urine and blood samples 
a 24 Hours urine was collected during the hospitalization of ten 
subjects 
b Both blood and urine samples of four subjects were taken on one 
or more days during the treatment period Venous blood samples 
were collected m heparimzed tubes at the following intervals from 
the time of application of the peeling paste, 0, 1, 3, 8, 12, and 24 
hours 
Urine samples were collected coinciding with the time of blood 
sampling The free plasma and urine 2-naphthol was extracted 
during the day of collection The samples were stored m a refrige-
rator until used (4° C) 
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2-naphthol 
Гід 11-1 Gas chromatogram of an extract from urine of a 
patient tieated with a 2-naphthol peeling paste 
RESULTS 
Calibration curves and recovery data 
The chromatograms of urine and plasma of control subjects showed 
no peaks interfering with the 2-naphthol peak. A gas chromatogram 
of patient's urine is shown in figure 11-1. The results of the calibration 
of the Chromatograph for 2-naphthol is shown in figure II-2. In order to 
check the recovery of 2-naphthol during the extraction procedure, 
known amounts of 2-naphthol were added to plasma and urine samples 
of control subjects. Tables II-1 and 11-2 summarize the recovery data, 
which proved to be satisfactory. 
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Fig. 11-2. Calibration of the gas Chromatograph by measurement of the peak height in 
mm from solutions with standard amounts of 2-naphthol in ng 
Table 11-1. Recovery data for 2-naphthol added to 5 ml urine samples. 
Amount of 2-naphthol 
to 5 ml urine 
in micrograms 
1.0 
1.0 
10.0 
10.0 
20.0 
20.0 
50.0 
50.0 
added Recovered amount 
of 2-naphthol 
in micrograms 
1.1 
1.1 
10.2 
10.1 
19.7 
20.1 
50.1 
49.5 
Percentage 
recovered 
107 
102 
100 
100 
Table II-2. Recovery date for 2-naphthol added to 2 ml plasma samples. 
Amount of 2-naphthol 
to 2 ml plasma 
in micrograms 
1.0 
1.0 
10.0 
10.0 
added Recovered amount 
of 2-naphthol 
in micrograms 
1.1 
1.1 
9.4 
9.5 
Percentage 
recovered 
108 
95 
a. 24 Hours urinary excretion data 
The 24 hours urinary excretion data during 24 days of treatment of 
patient no 5 are shown as an example in figure 11-3. Treatment of the 
back of the patients resulted m the highest amounts found in the urine. 
In figure 11-3 the open circles in the range 35-37 μg.ml"1 (50 mg- 146 
mg) all represent values during the application of the naphthol ointment 
to the back of the patient. 
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24 Hours urinary excretion data for 2-naphthol and total (free + con­
jugated) 2-naphthol from 9 patients during the period of treatment -
between 18 and 35 days - with 7 5 g 2-naphthol peeling paste are sum­
marized in table 11-3 The proportion of the amount recovered in the 
urine in relation to the applied daily dose of 1 5 g 2-naphthol, had a 
mean value of 5 % (over 250 applications) with a maximum of appro­
ximately 4 1 % The average percentage of free 2-naphthol present in 
the average amount of total excreted drug varied considerably in the 
patients, namely between extremes of 18% and 6 6 % , the mean being 
4 2 % Patient no 10 is also mentioned but was treated with a very small 
amount of peeling paste 
b Combined plasma and urine analyses 
From figure II-4 it can be seen that the plasma levels of free 2-naphthol 
were different for the seven test days of three patients A slight rise 
in the plasma level was observed which reached a peak level 12 hours 
after application of the ointment The highest value was approximately 
4 цд m l 1 Two days after the last application the free 2-naphthol began 
to disappear from the blood The plasma level of free 2-naphthol was 
far less than the plasma level of conjugated 2-naphthol The plasma 
levels of conjugated 2-naphthol determined for the same seven test 
days are shown in figure 11-5 In five tests the plasma levels of con­
jugated 2-naphthol reached peaks three hours after application of the 
ointment However m the other two tests, peak values were found 
eight hours after the application The highest mean peak level noted 3 
and 8 hours after the application of the ointment were 23 0 μg ml 1 and 
21 7 цд ml 1 Thereafter the levels decreased 24 hours after application 
of the ointment the mean value was 10 4 цд m l 1 The amount of con­
jugated 2-naphthol m the plasma of 2 patients 48 hours after the last 
application was 3 6 цд ml ' and 3 2 цд ml 1 respectively These values 
decreased further to 11 цд ml ' and 0 5 цд ml 1 the next day The 
elimination rate constants rei, of the conjugated 2-naphthol were 
obtained by means of graphical analyses of the plasma concentrations 
against time, using semiloganthmic graph paper (Van Rossum, 1971) 
The elimination rate constant, rei, being the reciprocal of the elimination 
time constant tei, and the apparent biological half-life, ti/2 ( ty = In 
-<-
Fig 11-3 Urinary free 2-naphthol and total (free + conjugated) 2-naphthol during 
hospitalization of patient no 5 Arrows indicate days of non-treatment 
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24 Hours 
Urinary Excretion of free 2-naphthol 
tient 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
mean 
μο-ιηΐ-' 
21 
27 
16 
11 
6 
23 
15 
32 
13 
0.4 
range 
μ9 ml-' 
4-47 
8-48 
2-40 
2-12 
2-11 
6-52 
2-39 
8-67 
5-23 
0- 3 
mean 
mg 
25 
36 
17 
18 
6 
31 
23 
66 
26 
5 
range 
mg 
8- 53 
13- 64 
3- 51 
3- 61 
2- 14 
8- 58 
2- 70 
11-188 
11- 44 
0- 5 
Table 11-3 
24 Hours 
Urinary Excretion of total 2-naphthol 
mean range mean range % 
ng ml"' μο-ίτι!-' mg mg free/total 
38 
46 
51 
20 
35 
77 
47 
50 
91 
3 
6- 97 
17- 73 
35-101 
8- 49 
10-179 
25-229 
11-133 
9- 99 
14-216 
0- 54 
51 
58 
54 
32 
40 
95 
71 
102 
198 
4 
12-146 
24-146 
2-141 
9- 76 
6-134 
36-309 
12-144 
14-278 
27-613 
0- 8 
61 
66 
29 
55 
18 
35 
46 
48 
18 
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Urinary excretion data of 2-naphthol and total 2-naphthol (free + conjugated) from patients treated with 7.5 g 
peeling paste. Patient no 10 is also mentioned but was treated with a very small amount of paste 
plasma 
2-n<s»phthol in u¿ / m l 
t ime in hours 
Fig 11-4 Plasma levels of 2-naphthol in several patients during the 7 hours exposure to 
a 20% 2-naphthol peeling paste and 17 hours thereafter. 
2хте0 calculated for the conjugated 2-naphthol from 4 patients are 
summarized in table II-4. 
The cumulative excretion data are shown in figure II-6. These urinary 
excretion data showed different values for each test day. The highest 
urinary excretion rates were observed during the first hours after 
application of the ointment. Unfortunately some urine samples were 
lost. 
DISCUSSION 
a. 24 Hours urinary excretion data 
The 24 hours urinary excretion data show that there is an average 
recovery of about 5 % of the dose applied to 300 cm 2 of the body 
surface. Harkness and Beveridge (1966) reported the recovery m 
urine as about 10% of the total amount of 2-naphthol applied in a 
peeling paste to about 2 0 % of the surface area of the subject. The 
difference in the results may very well have been caused by the dif­
ferent composition of the ointments used, (concentration, ointments 
base, etc.). Application of the ointment to the back of the patients 
27 
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Fig. 11-5. Plasma levels of conjugated 2-naphthol m several patients during the 7 hours 
exposure to a 20% 2-naphthol peeling paste and 17 hours thereafter. 
resulted in the highest urine values. Here the application area may 
have been greater than is realized during the application of the 
ointment, because of squeezing and spreading under the dressings. 
The amount of free 2-naphthol excreted in the urine as a percentage 
of the total amount excreted - mean value 4 1 % - is similar to the 
33-44% found in rats after subcutaneous injection of 2-naphthol 
(Berenbom and Young, 1951). There is a wide variation in these per-
centages of free 2-naphthol in our investigations. These different 
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Table 11-4. Elimination rate constant, rei, Elimination time constant, tei, 
and apparent biological half-life, ti/2, of conjugated 2-naphthol in four 
patients (when the human body is regarded as a smgie-compartmental 
reservoir). - indicates: one day after cessation of therapy. 
Day after start Amount of paste 
of therapy applicateci in g 
H 
H 
H 
H 
в 
в 
в 
L 
L 
J 
2 
14 
18 
31 
2 
11 
18 
3 
24 
23 
10 
10 
10 
— 
5 
5 
— 
10 
10 
percentages of excreted free naphthol may have been caused by dif­
ferences in metabolic capacity of the subjects and varying pH of the 
urine investigated. The passive tubular reabsorption of the unchanged 
drug, being a weak acid, will depend on the amount of lipid soluble, 
non-ionized naphthol present, which is strongly dependent on the pH 
of the urine. The maximum concentration found in urine was 67 μg 
free naphthol per ml urine. 
b. Combined plasma and urine analyses 
The clinical effect of the application of a 2-naphthol peeling paste 
(Powell, 1970) and the toxicological aspects of this treatment have 
been considered to result from the penetration of this drug through 
the skin. However, there has never been any reliable report on plasma 
levels of 2-naphthol. If we suspect the occurence of an intoxication due 
to this compound, we have to realize that the 2-naphthol plasma con­
tent will not give real information about the degree of exposure of the 
Area of 
applicatio 
(300 cm2) 
face 
face 
back 
face 
face 
face 
face 
'el 
m h r ' 
0.031 
0.039 
0.021 
0.050 
0.079 
0.066 
0.073 
0.063 
0.086 
Tel 
in hr 
32.3 
25.6 
47.6 
20 0 
12.7 
15.2 
13.7 
15.9 
11.6 
U/2 
in hr 
22.4 
17.8 
33.0 
14.0 
8.8 
10.5 
9.5 
11.0 
8.1 
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subject to this drug The content of free 2-naphthol remains nearly 
constant at a low level soon after 2-naphthol has entered the circulation 
(figure 11-4 and 11-5) Besides, the ratio of free naphthol to conjugated 
naphthol in the plasma appeared not to be constant The appearance 
and occurence of conjugated 2-naphthol in the plasma is apparently 
"capacity-l imited" m that it obeys zero order kinetics The 2-naphthol 
therefore seems to be readily absorbed and conjugated Conjugation 
and renal excretion of the unchanged drug seems to be the principal 
mechanisms of elimination. 
u r i n e 
2 - n a p h t h o l in m g 
f r e e 2-naphthol 
c o n j u g a t e d 2-naphthol 
1 1 1 1 1 1 
О Λ 8 12 16 20 24 
t i m e in hours 
Fig II-6 Cumulative excretion of free 2-naphthol and conjugated 2-naphthol m the 
patients mentioned m fig II-4, II-5 and table II-4 
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The long-lasting plasma level of 2-naphthol is supposed to be caused 
by absorption from depots upon, and in, the skin and other tissues, 
from tubular reabsorption and enterohepatic circulation of the drug 
(Williams, Millburn and Smith 1965; Smith 1966; Wagner 1971; 
Riegelman 1971). In 10 experiments with 4 different subjects the 
apparent biological half life (ty2) of conjugated 2-naphthol varied 
between 8 hr and 33 hr. 
The present absorption studies of topically applied 2-naphthol in a 
so-called peeling paste, again confirm the finding of the accumulation 
of 2-naphthol in man reported by Lesnik and Nencki as early as 1886. 
Our experiments revealed a considerable percutaneous absorption of 
2-naphthol, even through undamaged stratum corneum which is usually 
considered to be the rate limiting barrier. Treatment of the skin with a 
peeling paste, however, often changes the conditions by impairment 
of the skin barrier in such a way, that percutaneous absorption occurs 
even more readily (Montagna and Lobitz, 1964; Blank and Scheuplein, 
1969). 
A potential hazard may be created particularly in patients with 
widespread acne, because they, usually and preferably, are treated 
during a prolonged period over a relatively large fraction of the body 
surface. Therefore we propose that it should be made a rule that the 
ointment is only applied to limited areas - 300 cm2 - , and only to 
patients with a normally active glucuronidatmg system. The patient 
should be followed closely during therapy with careful clinical and 
laboratory observations. The ointment should preferably not be left 
on the skin for more than one hour. A repeated treatment carried out 
twice a day for such a short time is preferable to one long exposure. 
A high urine production - preferably alkaline - must be ensured. It is 
obvious that pregnancy is a containdication for such a therapy. 
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CHAPTER III 
PHARMACOKINETICS AND DISTRIBUTION 
OF 2-NAPHTHOL IN DOGS 
SUMMARY 
Plasma levels and urinary excretion data of 2-naphthol and its con­
jugates were measured in dogs, following intravenous administration 
of the drug. One dog received 480 mg 2-naphthol in 60 minutes in each 
of two experiments. The other dog received 200 mg 2-naphthol in 107 
and 286 minutes in each of two experiments. 
The concentration of 2-naphthol in the plasma in the first mentioned 
experiments reached a level of approximately 30 цд.ті'1, and the con­
centration decreased rapidly after the infusion was stopped. The 
plasma level of the drug has been described, using a two-compartment 
open model. In the experiments with a lower dose of the drug, the 
plasma 2-naphthol level remained low, even at peak level. The plasma 
conjugated 2-naphthol concentration rapidly increased during the in­
fusion. It took a long time before the conjugated 2-naphthol disappeared 
from the plasma. The urinary excretion rate of both 2-naphthol and 
conjugated 2-naphthol was non-linearly with their level in the plasma. 
INTRODUCTION 
Earlier studies of the percutaneous absorption of 2-naphthol in man 
indicate that this drug rapidly penetrates during therapeutic application 
to the skin (Harkness and Beveridge, 1966; This dissertation, chapter 2). 
An adequate study of the absorption should therefore be carried out, 
and, consequently, the pharmacokinetics following an intravenous dose 
should be defined. The toxicity of 2-naphthol has always hampered 
such studies. This difficulty has been overcome by administering the 
drug to dogs, which have as strong a glucuronidating system as man 
Discussions and comments with Prof. Dr. S. Riegelman - School of Pharmacy, Univer­
sity of California, San Francisco - concerning this chapter have been very valuable to me. 
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has The course of the plasma 2-naphthol concentration following 
application of the drug m a peeling paste to the skin is, to some extent, 
mimicked by a constant-rate infusion 
This chapter deals with the measurement of plasma levels and urinary 
excretion of the drug following such intravenous infusion in dogs 
Using these data, classical pharmacokinetic techniques allow an 
appraissal of the distribution and elimination of the drug With the 
aid of this knowledge it is possible to evaluate the plasma concen­
trations of the drug after application of the drug to the skin m different 
peeling pastes 
MATERIALS AND METHODS 
The dogs, a beagle (body weight 10 kg) and a mongrel dog (body 
weight 17 kg) were maintained m a sedated condition throughout the 
entire experiment After induction with 20 mg pentobarbital per kg body 
weight, they inhaled a mixture of oxygen, nitrous oxide and halothane 
(2 1 0 05) A parenteral solution of 2-naphthol was prepared as fol­
lows One g 2-naphthol was dissolved in 100 ml ethanol and filtered 
through a sterilizing filter An aliquot of this solution was added, under 
aseptic conditions, to a sterilized mixture of ethanol, glycerol and 
water (26 33 42) to a final volume of 50 0 ml Fifty ml 2-naphthol 
solution was delivered via a canulla to the leg vein by means of an 
infusion pump at a constant rate 
In experiments I and II 480 mg 2-naphthol was given in 60 minutes to 
the beagle Two hundred mg 2-naphthol was given to the mongrel dog 
in 107 minutes (Experiment III) and m 286 minutes (Experiment IV) 
Blood samples were taken from the jugular vein at various intervals 
after the start of the 2-naphthol infusion Approaching the end-point 
of the infusion some additional samples were taken In one experiment 
blood samples were additionally taken up to 200 hours after the start 
of the infusion The sample was collected m a heparmized test tube, 
centnfuged, and the plasma stored at 4° С until required for analyses 
In two experiments all urine was collected from a catheter The extrac­
tion methods and the determination of free 2-naphthol and total 
2-naphthol are described in chapter II 
The drugs used were Dutch Pharmacopoeia Ed VI grade 
PHARMACOKINETIC ANALYSIS 
Individual and mean plasma 2-naphthol levels during and after the in­
travenous infusion of 480 mg 2-naphthol in 60 minutes were subjected 
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to kinetic analysis Pharmacokinetic analyses of the plasma level data 
was accomplished by fitting theoretical curves to the experimental 
data 
The calculations are based on the two compartment open model, shown 
in the diagram, 
Vi 
3 ko Ί L¿£L· 
- ! • 
k i o 
kei 
• 
2 
m which 3 represents the infusion pump, 1, represents a central rapidly 
equilibrating body compartment which includes the plasma, 2, a more 
slowly equilibrating body compartment, Vi, the apparent volume of 
distribution of the central compartment, ko, a fixed zero order constant 
(constant rate infusion) ki2 and k2i are the clearance constants 
governing the equilibration of 2-naphthol between compartments 1 and 
2, kei is the overall elimination clearance constant 
When the body is considered as a central compartment with one 
additional compartment, the semiloganthmic post infusion plasma con-
centration time curve is not a straight line, but is biphasic In this case 
(Van Rossum, 1971), the post infusion distribution and elimination 
processes could be described by two linear differential equations 
leading to the following solution 
Cpost (t*) = A i * e t*A' + Аз* e-t*/t2 (Equation 1) 
where Cpost (t*) equals the concentration in the first or central com­
partment, Ai* and A2* are the coefficients - the intercepts of the 
exponential terms - τι and тг are the time constants (reciprocal rate 
constants) and t* is the time after the end of the infusion 1 e t* = t — T, 
where Τ is the infusion time 
From the post infusion plasma concentration time curve Ai* and A2* 
are obtained from the intercepts of the lines representing the slopes 
1 1 
π ( = — ) and Г2 ( = — ) with the line parrallel to the ordinate at t = 
τι τι 
60 minutes (end of the infusion) π and гг are obtained from the slopes 
by "stripping" of the post infusion curves using semiloganthmic graph 
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paper. The time constants, τι and τι m equation (1) are the same 
whether obtained from a post infusion curve or a single intravenous 
bolus curve. 
During the infusion the plasma concentration time curve is describable 
by the following equation (Loo and Riegelman, 1970; Van Rossum, 1971 ; 
Wagner, 1971): 
G = Α ι . — . (1 - e-t/τι) + Аг — (1 - e-*/™) (Equation 2) 
where Α ι and Аг are hypothetical intercepts with the ordinate for an 
intravenous bolus injection of the same amount of drug (i.e. Τ = 0). 
Α ι and Ai are different from A i * and A2* (Equation 1); these differences 
increase as the infusion time, T, lengthens. The intercepts Ai and A2 
have been calculated from the following equation as described by Loo 
and Riegelman (1970): 
T/tl Т/Т2 
A i = Α ι * . and A2 = A2*. (Equation 3) 
1 - e-T/ti 1 - e-TA" 
From these hypothetical intercepts and the time constants the phar­
macokinetic parameters intrinsic to a two compartment open model 
have been calculated from the equations summarized in table III-1, 
as described by Van Rossum (1971). 
Table III-1. Pharmacokinetic parameters for the two compartment open 
model and intravenous administration according Van Rossum (1971) *) 
A i + A2 = A T1A1 + тгАг = AT Vi = D/A 
ty2 = 0 693 T2 kei = D/AT 
rei = kei/Vi = A/AT Г21 = к г і / г = АТ/т ітгА 
Гі2 = ki2/Vi = ( n + Г2) — (ral + Г2і) = А і А г (т2 - τ ι ) 2 / Α ΑΤτιτ2 
Vf = V i (1 + П2/Г21) = D ( τ ι 2 Α ι + τ 2 2 Α 2 ) / ( Α Τ ) 2 
B2V2 = D A i A 2 (т2 - τ ι ) / А . А Т 
*) In this paper the notation r is used for the elimination rate constants and the notation 
к for the clearance constants (Van Rossum, 1971) 
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The eliminated quantities Qei (by metabolic, renal routes, etc.) of the 
drug and the quantities in the central compartment Qi and in the 
peripheral compartment Q2 have been calculated as function of time 
using the following equations: 
During the infusion Qeim = kei \ Ct dt (Equation 4) 
and post infusion 
Qei = Qeim + kei ( A i t i (1 - e-f/t i) + Азтг (1 - e-t*/") (Equation 5) 
The quantity in the central compartment, Qi = Ox Vi (Equation 6) 
and the quantity in the peripheral compartment 
\\ \ \ 
Q2 = D — (Qei + Qi) (Equation 7) 
plasma 
2-naphthol i n ^ i g / m l 
100 
5 0 -
ê conjugated 2 -naph tho l 
о mean 2 - n a p h t h o l 
1 г r 
6 7 8 
t ime in hours 
Fig. 111-1 Plasma levels of 2-naphthol and conjugated 2-naphthol during and following 
an intravenous dose of 4Θ0 mg 2-naphthol in 60 minutes (Experiment I and II). Data 
points (o) represent experimentally determined mean plasma level and the continous 
line is the calculated level of 2-naphthol. 
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RESULTS 
The plasma concentrations of 2-naphthol and conjugated 2-naphthol 
(experiment I and II) during and after constant rate infusion of 480 mg 
in 60 minutes are shown in figure III-1. Peak levels of 36.5 μg|m\ and 
22.2 μg/ml after constant rate infusion occurred at 60 minutes in both 
cases. 
The grossly observable effect of treatment was haematuria and signs 
of airway irritation, with bleeding from the nose. However, soon after 
the end of the infusion these effects disappeared. 
The kinetic constants calculated from the post-infusion plasma level 
are summarized in table III-2. 
Table III-2. Pharmacokinetic parameters for the two-compartment open 
model of 2-naphthol calculated from the constant rate intravenous 
infusion of 480 mg 2-naphthol in 60 minutes in a beagle of 10 kg 
bodyweight. 
Calculated from 
Parameter Experiment I Experiment II Mean value the mean plasma 
concentrations 
Ai 
A2 
A 
AT 
η 
Г2 
τι 
Τ2 
Vi 
kei 
ГеІ 
Г12 
Г21 
kl2 
Vf 
В2 : 
( т д . І 1 ) 
( т д . І 1 ) 
( т д . І 1 ) 
(mg.l-'.hr) 
( h r ' ) 
(hr 1 ) 
(hr) 
(hr) 
(I) 
( l .hr 1 ) 
(hr1) 
( h r ' ) 
(hr 1 ) 
( l .hr 1 ) 
(1) 
! (mg) 
96 
7.4 
102.5 
50.4 
4.1 
0.28 
0.25 
3.57 
4.7 
9.6 
2.0 
1.7 
0.55 
8.0 
19.2 
219 
74 
7.5 
81.5 
47.6 
4.6 
0.23 
0.22 
4.17 
5.9 
10.1 
1.7 
2.4 
0.64 
14.2 
28.0 
271 
85 
7.5 
92.0 
49.0 
4.4 
0.26 
0.24 
3.87 
5.3 
9.9 
1.9 
2.1 
0.60 
11.2 
23.6 
245 
83 
6.1 
89.4 
53.2 
3.6 
0.20 
0.28 
4.90 
5.4 
9.0 
1.7 
1.7 
0.40 
8.9 
25.9 
231 
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quantity in 
mg 2-naphthol 
460 
100 % 
360-
240-
120-
4 5 
t ime in hours 
Fig N1-2 Quantities of 2-naphthol in the central compartment (Qi), the peripheral com-
partment (Çh) and the quantity eliminated (Qe|) as function of time according to a two 
compartment open model and constant rate intravenous administration (k0) of 480 mg 
2-naphthol in 60 minutes to a dog of 10 kg body weight. 
The continuous line in figure 111-1 represents the calculated plasma level 
of 2-naphthol using the parameters of the mean experimental data. 
The quantities in the two compartments as well as the quantity elimi-
nated calculated by using equations 4, 5, 6 and 7 from the mean ex-
perimental data are shown in figure III-2. 
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The results of the plasma and urine analyses during and after a con­
stant rate intravenous infusion of 200 mg 2-naphthol in 107 minutes 
- Experiment III - and in 286 minutes - Experiment IV - are shown in 
figure III-3 and figure III-4, respectively. In comparison to the first two 
plasma 
2-naphthol in ^ug/ml 
200 
100-
50 
20 
10 
5 
о conjugated 2-naphthol 
• 2-naphthol 
renal excretion rate 
myuç/min 
200 
100 
conjugated 2-naphthol 
2-nap) i thol 
time in hours 
6 7 θ 
time in hours 
Fig. III-3. Plaama curve of 2-naphthol and conjugated 2-naphthol during and following 
a constant rate intravenous infusion of 200 mg 2-naphthol in 107 minutes to a dog of 
17 kg (Experiment III) and the renal excretion rate of 2-naphthol and conjugated 
2-naphthol during the same experiment. 
plasma — 
2-naphthol in μξ/ml 
200-| о conjugated 2-naphthol 
I Q Q I · 2-n<3phthol 
50 
20 
10 
5 
renal excret ion r a t e 
in μζ/тіп 
200 
100 
50 
20 
10 
5 
1 2 3 4 5 6 
t i m e in hours 
conjugated 2-naphthol 
2-naphthol 
6 7 0 
t i m e in hours 
Fig. III-4. Plasma curve of 2-naphthol and conjugated 2-naphthol during and following 
a constant rate intravenous Infusion of 200 mg 2-naphthol m 286 minutes to a dog of 
17 kg (Experiment IV) and the renal excretion rate of 2-naphthol and conjugated 
2-naphthol during the same experiment. 
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experiments the plasma 2-naphthol concentration remains low and 
only a brown-red urine color was observed. The plasma concentration 
of 2-naphthol and conjugated 2-naphthol measured during a prolonged 
period after the end of the infusion of 200 mg 2-naphthol in 107 minutes 
is shown in figure III-5 (Experiment III). 
picisn 
2-na 
1 0 0 -
5 0 -
2 0 -
1 0 -
5 -
0 _ 
1 -
lol 
ohtho 
о * 
3 
» 
in ug/ml 
S 
0 0 
· · 
ι ι 1 I 
о conjugate-d 2-naphthol 
• 2 -nó iph tho l 
о 
ι — ι 1 1 1 ι—' 
4 0 80 ICO 160 2 0 0 
t i m e in h o u r s 
Fig. III-5 Plasma concentration of 2-naphthol and conjugated 2-naphthol measured 
during a prolonged period after the end of the infusion of 200 mg 2-naphthol in 107 
minutes (Experiment III) 
DISCUSSION 
Any mathematical model used to describe a biologic system is bound 
to be a gross oversimplification. It is important therefore, to choose 
the least complicated model system which as closely as possible 
mimics the measurable biologic parameters With a one compartment 
open model, 2-naphthol plasma levels could adequately be simulated 
during the constant rate intravenous infusion, however, there was a 
difference between the calculated and observed post infusion plasma 
level. When the same data were analysed with the animals body 
described by a two compartment open model, the calculated post in­
fusion plasma concentrations were much closer to the experimental 
data. Although there was still a difference between the calculated and 
experimental data, it was felt that any further complication of the model 
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was not justified without accurate analytical measurement of 2-naphthol 
concentrations in tissues other than the blood With the two compart­
ment open model, 2-naphthol plasma levels could be simulated during 
and after stopping a constant rate infusion of 480 mg 2-naphthol in 60 
minutes as shown in figure 111-1 
The graphical techniques used may have contributed to the differences 
m the pharmacokinetic parameters listed m table III-2. However, these 
estimates may be refined by use of an iterative nonlinear estimation 
program, based on the method of least squares, and a high speed 
digital computer. 
The biological significance of some of the absolute values for the 
various model parameters merits comment However, due to the sim­
plicity of the mathematical model, the rate constants and clearance 
constants generally reflect a combination of many processes and, 
therefore, are difficult to interpret On the other hand, the apparent 
volume of distribution of the central compartment, Vi, allows some in­
terpretation The calculated magnitude of this parameter indicates that 
even m the rapidly equilibrating central compartment, 2-naphthol must 
be extravascularly concentrated, for the mean value of this constant 
(5 4 liter m the dog of 10 kg) being 0 54 I kg 1 is approximately 6 times 
the normal expected volume of the blood, being 0 09 I kg ' (Jones, 1957) 
As for this apparent anomahty, Riegelman, Loo and Rowland (1968) 
have concluded that highly perfused tissues such as kidneys, lung and 
liver might be included in the central compartment of models identical 
to the model used. 
The total fictive volume of distribution for 2-naphthol, Vf, is even larger 
The drug remains in the body for a long time, notwithstanding the large 
clearance. It is customary to calculate the biological half-life from the 
largest time constant or the slowest component in the plasma curve 
(ι e. disposition rate constant) This ty2 has no direct relevance to the 
fictive volume of distribution and elimination clearance constant 
In the mentioned first experiments, the rate of infusion has to some 
extent exceded the rate of detoxication and excretion Observation of 
the dog during the experiments does suggest that the toxic level of the 
drug has been passed As may be seen from figure 111-2,20% of the 
drug remains m the body 4 hours after the end of the infusion The 
eliminated*) 2-naphthol has not been total excreted, but most of it 
remains in the body as conjugated 2-naphthol 
*) The term "eliminated' is used here to include that portion eliminated in the excreta 
as well as that part metabolized in the body 
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In experiments III and IV the dose was lowered in order to avoid 
damage to the detoxication and excretion mechanisms In both ex­
periments the plasma 2-naphthol concentrations were markedly lower 
than the levels observed in the first two experiments Even at its 
maximum, the level is too low to allow calculations of the kinetics in the 
same way as m the former experiments 
It is usually presumed that the excretion rate of compounds is propor­
tional to the blood level of the compound, ι e dQr/dt = kr Ci where 
dQr/dt is the renal excretion rate (figure III-3 and III-4), kr the renal 
clearance constant and Ct, the concentration in the plasma The cal­
culated renal clearance from the plasma levels and urinary excretion 
rate of experiment III (figure III-3) are summarized in table III-3 
Table III-3 Relation between the plasma concentration and urinary 
excretion of 2-naphthol and conjugated 2-naphthol after an intravenous 
infusion of 200 mg 2-naphthol in 107 minutes m a mongrel dog of 17 
kg - Experiment III -, see figure III-3 
Time 
in minutes 
2-naphthol*) 
150 
330 
Conjugated 2-
150 
330 
naphthol*) 
dQr/dt 
in μς mm ' 
25 0 
83 
156 
15 
c, 
in μ9 ml ' 
22 
23 
35 4 
28 0 
m ml mm ' 
11 4 
36 
44 
05 
*) Interpolated from graphs in figure III 3 
From this table, it clearly appears that both the free 2-naphthol and 
the conjugated 2-naphthol are excreted non-lmearly with their level in 
the plasma The assumption of the proportionality of plasma concen­
tration and urine excretion rate holds if there is no protein binding and 
provided that the urine pH is constant and that tubular secretion is 
concentration independent Its known from phenols, that they are highly 
protein bound (Deichmann, Witherop and Dierker, 1952) and most 
probably naphthol will behave similarly Besides, preliminary experi­
ments showed that there was an excretion of conjugated 2-naphthol 
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into the gallbladder A proposed enterohepatic cycling, together with 
the protein binding of 2-naphthol, could be the reason why no linear 
relationship between the plasma level and the urinary excretion rate 
was demonstrable 
It is generally accepted that naphthol is metabolized into its con­
jugates with sulphuric and glucuronic acids (Lesmk and Nencki, 1886, 
Berenbom and Young, 1951, Boyland and Wiltshire, 1953, Harkness, 
Beveridge and Davidson, 1971) The results of these studies show that 
the excreted conjugated 2-naphthol during the first day after the dose 
was mainly present in the glucuromde fraction and after the first day, 
the sulfate conjugate began to predominate The observation that the 
metabolite remaining m the plasma for a prolonged period was 
hydrolysed by sulfatase and not by glucuronidase confirmed this 
hypothesis Data obtained from the literature by Bray, Thorpe and 
White (1952) show that for phenols the percentage of the dose excreted 
as glucuromde increases with dose In our experiments the same can 
be concluded 8 1 mg and 0 0 mg conjugated 2-naphthol is excreted 
at t = 105 minutes during infusion rates of 1 9 mg mm ' and 0 7 mg mm ' 
respectively Glucuromde conjugation follows first order kinetics, 
whereas the sulfate conjugation takes place at a uniform rate (Bray, 
Thorpe and White, 1952, Levy and Matsuzawa, 1967; Bmklley, 1949) 
Probably the metabolite excreted is mainly naphtholglucuromde and 
therefore the relationship with the composite of both metabolites m the 
plasma is not linear 
It can be calculated from the results of experiment III and IV, that an 
increase in the plasma total 2-naphthol of 1 μg ml 1 mm ' corresponds 
to a dose of approximately 5 7 mg mm ' (see table III-4) Experiments 
Table III-4 The relationship between the increase m plasma total 
2-naphthol concentration and the infusion rate 
1 цд ml , min ' 
Increase in plasma increase in plasma 
Experiment Dose in mg mm 1 total naphthol in total naphthol 
цд ml ' mm ' corresponds with 
a dose of 
III 1 87 0 34 5 5 mg mm ' 
IV 0 70 0 12 5 8 mg mm ' 
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¡η the same dog show that the increase in the plasma total 2-naphthol 
after application of 2-naphthol to the skin was a function of the surface 
area to which the naphthol was applied (see chapter IV fig. IV-1). 
This will allow comparison of data of the constant rate infusion with 
the percutaneous absorption experiments. 
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CHAPTER IV 
PERCUTANEOUS ABSORPTION 
AND BIOPHARMACEUTICS OF 2-NAPHTHOL 
SUMMARY 
2-Naphthol in different ointment compositions, was applied to the 
flanks of an anesthetized mongrel dog Blood and urine samples were 
withdrawn at intervals and analyzed for 2-naphthol and its conjugates 
2-Naphthol conjugates were detectable in jugular vein blood withdrawn 
5 minutes after application of the drug to the flanks After a lag-time of 
approximately 45 minutes the conjugated 2-naphthol concentration in 
the plasma rose rapidly during the first hours The concentration of 
free 2-naphthol m the plasma remained low, ι e the rate of absorption 
was lower than the rate of detoxication Urine 2-naphthol and con­
jugated 2-naphthol content were negligible during the period in­
vestigated 
The penetration rate increased with increasing concentration of 
2-naphthol in the ointment up to 5%, at which concentration a maximum 
penetration rate was reached The permeability coefficient of 2-naphthol 
appeared to be dependent on the concentration of the drug m each 
different ointment The permeability coefficient decreased with in­
creasing concentration 
Ointments with soap added reached a maximum penetration rate at 
approximately twice the rate reached without soap 
INTRODUCTION 
In m-vivo experiments percutaneous absorption is often studied by 
measuring the amount of material penetrating the skin by means of 
analysis of the amount excreted m the urine In such studies often 
little is known about what happens to the substance between the time 
it penetrates the skin and the time that it is excreted Critical remarks 
about such studies have frequently been made Scheuplem and Blank 
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(1969) remark "It is obvious that transport in such a system is a com­
plex phenomenon and difficult to analyse" 
In a previous investigation (Chapter III) the constant rate intravenous 
infusion technique was, therefore, applied to study the concentration 
of 2-naphthol reached in the plasma under defined conditions From 
this a model has been presented describing the results of these ex­
periments Some processes have been explained Yet there remains 
a gap between the understanding of the processes involved and the 
practical application of 2-naphthol in the dermatological clinic 
From a toxicological point of view it is important to maintain the con­
centration of 2-naphthol in the body and the plasma below the level 
which yields toxic effects The amount of penetrated substance is 
dependent on the nature of the penetrating molecules, the base of the 
ointment, the concentration, the size of the area of application and the 
properties of the skin These properties, that is to say the "quality" 
of the skin, are especially important in the clinic since a peeling 
ointment is applied and the skin is consequently severely injured 
Following the injury the systemic absorption of the 2-naphthol may 
become increasingly more important if the barrier due to intracutaneous 
absorption is nearly lost 
In this chapter we describe the results after absorption of various 
concentrations of 2-naphthol in a peeling ointment through the skin of 
a dog 
MATERIALS AND METHODS 
A mongrel dog (17 kg) was maintained in a sedated condition as 
described in Chapter III The flank of the dog was shaved with an 
animal clipper Thirty g 2-naphthol containing ointment was applied 
onto an area of 18 χ 23 cm2 with a wooden spatula and the area covered 
with cloth The compositions of the various ointments investigated are 
summarized in table IV-1 The quality grade of the ingredients has been 
described before (Chapter II and III) 
Several experiments were carried out using the same dog at 14 day 
intervals on alternating flanks, so that the area treated could recover 
during a period of a month Blood samples were drawn from the 
jugular vein into hepanmzed tubes at various intervals from the moment 
of application of the ointment Urine samples were taken from a 
catheter 
The extraction methods and the determination of free 2-naphthol and 
conjugated 2-naphthol are described in Chapter II 
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Table IV-1 The composition (in % by weight) of the various ointments 
tested 
MENT nr 
1 
II 
III 
IV 
V 
VI 
VII 
2-naphthol 
1 
3 
5 
20 
1 
5 
20 
soft soap 
5 
5 
5 
20 
— 
— 
sulphur 
20 
20 
20 
20 
20 
20 
20 
soft paraffin 
74 
72 
70 
40 
79 
75 
60 
Total 
100 
100 
100 
100 
100 
100 
100 
TREATMENT OF DATA 
When the amount of substance penetrating the skin is plotted against 
time, a straight line results as soon as a steady penetration rate (r) 
has been reached (Treherne, 1956, Scheuplem and Blank, 1971) The 
value of r is obtained from the slope of the curve It has been found 
that an increase m the plasma total naphthol of 1 цд ml ' mm ' corres­
ponds to a dose of 5 7 mg mm 1 (Chapter III and figure IV-1), and 
therefore this factor has been used to calculate the rate of penetration 
of 2-naphthol from local applications on the skin The mathematical 
course is less simple during the so-called "lag-time" (L) before the 
steady penetration rate is reached (Caneghem, 1969) The value of L 
has been derived from the curve by extrapolating the straight line of 
the steady penetration rate to an intersection with the horizontal time 
axis 
According to Pick's law r = dQ/dt = K A C 
In this equation r — dQ/dt is the rate of penetration, К is the per­
meability constant and ДС is the difference in 2-naphthol concentration 
between the outside and inside of the skin The ДС m the experimental 
circumstances can be considered to be similar to the concentration of 
2-naphthol at the surface of the skin, since the 2-naphthol concentration 
in the blood (inner milieu) is negligible It is held at a low level by 
biotransformation (Chapter III) The value of ДС is dependent on the 
value of the concentration of the 2-naphthol in the ointment (Cn), 
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as AC = f Cn In this equation f is the partition coefficient, representing 
the distribution of the 2-naphthol between the ointment and the surface 
of the skin Accordingly r = К f Cn The product К f has been called 
the ' apparent permeability constant' and has been calculated from 
К f = r/C» The dimension is similar to the dimension of the permea­
bility constant being calculated by dividing r in ц д с т 2 т і п by Cn in 
μg cm 3 (derived from the percentage by weight by considering the 
specific gravity of the ointments, being about 09 gem 3 ) and resulting 
in units of cm mm ' 
р і а ь т а 
2-naphthol in /-ig /ml 
3 0 Ί
 DOG 1209 
20% 2-naphthol ointment without soap 
о application a r e a 414 cm 0 
Δ application a r e a 207 cm 
20 
10-
A A 
τ 
3 
π 1 
5 6 7 
time in hours 
г 
2 
Fig IV-1 Increase in the concentration of 2 naphthol (free + conjugated)in the plasma 
of a mongrel dog following application of 20% 2 naphthol ointment without soap 
(Table IV-1 no VII) to respectively 414 cm2 (A) and 207 cm2 (B) skin of the flank The 
slope of these curves, dCp/dt are respectively 0 08 μg ml ' mm ' (A) and 0 04 
цд ml 1 mm ' (B) 
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RESULTS 
2-Naphthol, when applied to the shaved skin of the dog in the different 
ointments, was rapidly absorbed and was detectable within 5 minutes 
in the plasma of the blood samples obtained from the jugular vein. 
The lag-time varied approximately between 30 and 60 minutes. The 
blood concentration of free 2-naphthol remained low throughout the 
experiments. The rate of absorption was below the rate of detoxication. 
During the investigated application times, 2-naphthol and 2-naphthol 
conjugates in the urine were negligible. 
Typical curves for the appearance of 2-naphthol in the plasma of the 
dog after application of a 2-naphthol containing ointment to the flank 
of the dog are shown in fig. IV-1. 
The mean values of the slopes of the curves (dCp/dt) of some similar 
experiments are presented in table IV-2. The table also summarizes 
the penetration rate (r) and the apparent permeability constant (pi) 
found from the results of tests with various ointment compositions. 
The penetration rate of 2-naphthol in relation to the percentage of 
2-naphthol in the ointment with soap as applied to the flanks of a dog 
is shown in fig. IV-2. 
penetrat ion r a t e 
. _ 2 · - 1 
in /jg.cm .mm 
2.0 
1.5-
1.0-
0.5 
τ — ι — ι — ι ι ι—I - ~i—ι—r - !—г—г 
8 10 12 14 16 18 20 
% 2-naphthol in the ointment 
Fig. IV-2 The penetration rate of 2-naphthol in relation to the percentage of 2-naphthol 
in the ointment as applied to the flanks of a dog. 
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S Table IV-2 
The steady appearance rate of 2-naphthol (dCP/dt) in the plasma of a mongrel dog (mean values ± standard 
deviation); the penetration rate (r); and the apparent permeability constant (pk) following application of various 
ointments, mentionned in table IV-1. 
OINTMENT composit ion 
nr 
dCp/dt 
¡π μ9 ml Ί mirr 1 
I 1% 2-naphthol with soap 0.04 ± 0.008 
II 3% 2-naphthol with soap 0.08 ± 0.010 
5% 2-naphthol with soap 0.12 ± 0.006 
IV 20% 2-naphthol with soap 0.13 ±0.009 
V 1 % 2-naphthol without soap 0.05 ± 0.007 
VI 5% 2-naphthol without soap 0.08 ± 0.013 
VII 20% 2-naphthol without soap 0.08 + 0.012 
r 
m цд сп 2 
0.5 
1.1 
1.7 
1.9 
0.7 
1.2 
1.1 
mm ' m 10 
Pk 
6
 cm mirr' 
55 
41 
37 
11 
77 
26 
6 
DISCUSSION 
The ability of the drug to be transported to the site of absorption, the 
skin, the ability of the drug to penetrate through the skin membrane 
(intracutaneous absorption), and the ability to penetrate from the 
dermal tissue into the circulatory system of the body (systemic 
absorption), are all important considerations (Scheuplem and Blank, 
1971, Blank and Scheuplem, 1969, Hlynka, Anderson and Riedel, 1969', 
1969" Idson, 1971) 
In our m-vivo investigations measuring the percutaneous absorption 
of 2-naphthol, this absorption is effected through perhaps a damaged 
skin The usual barrier of the skin, the stratum corneum, can be sup­
posed to be damaged and the systemic absorption may be of some 
account m these circumstances As Scheuplem and Blank (1971) have 
shown, it should be possible that the transport into the blood capillaries 
and the blood flow may not be fast enough to assure that the rate 
at which penetrating molecules accumulate by diffussion near to the 
capillary system is less than the blood perfusion rate Under such 
conditions the rate of systemic absorption is controlled by the transfer 
of molecules into the capillaries and not by diffusion through the 
stratum corneum of the skin The transfer resistance offered by per­
fusion is approximately 102 cm ' mm according to Scheuplem and 
Blank (1971) The diffusional resistance (FUrf = 1/pk) calculated from 
the apparent permeability constants summarized in table IV-2 varied 
between 130 χ 102 and 1700 χ IO2 cm 1 mm Thus the diffusional resistan­
ce is at least about 100 times the transfer resistance offered by per­
fusion Evidently the percutaneous absorption of 2-naphthol is not 
limited by blood perfusion 
For most substances the rate of penetration is limited by the imper­
meability of the skin Therefore at least in first instance, Pick's law is 
most appropriate to describe the phenomena 
The amount of 2-naphthol absorbed per unit time and per unit area 
(the penetration rate) increased approximately linearly with increasing 
concentration up to about 5% 2-naphthol as might be expected from 
Pick's law, see figure IV-2 At a concentration of 20% 2-naphthol the 
absorption occurs at nearly the same rate as at a concentration of 
5% 2-naphthol m the ointment however Similar apparently anomalous 
deviations from Pick's law have been described before in the literature 
m relation to the absorption of other substances (eg 1-pentanol in 
olive oil, mercuric chloride) through the skin (Skog and Wahlberg, 
1964, Blank and Scheuplem, 1964, Wahlberg, 1968) As is evident from 
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table IV-2 this phenomenon finds expression in the apparent permea-
bility coefficient, pu, decreasing with increasing 2-naphthol concen-
tration. The theoretical permeability coefficient, K, should be indepen-
dent of the concentration. It is reasonable to suppose that the partition 
coefficient, f, is much influenced by the ointment composition (pk = K.f). 
A good estimation of the partition coefficient for skin applications is 
not yet available. 
From experiments with phenol the apparently anomalous phenomenon 
that some lower concentrations of phenol applied to the skin may result 
into higher concentrations of phenol in the blood has been described 
(Deichmann, Witherup and Dierker, 1952). Possibly 2-naphthol behaves 
similarly to some extent. A possible contribution to the understanding 
of this anomalous behaviour has been given by other investigators 
(Malten, Spruit, Boemaars and de Keizer, 1968), who demonstrated that 
the skin's water barrier is denaturated by phenol into a more im-
permeable one. It is, however, difficult to understand how such an 
effect should interfere in our experiments m the case of the application 
of the ointment composition containing 20% 2-naphthol since the skin 
barrier is probably thoroughly damaged by this ointment composition. 
The influence of soap, obvious from the different heights of the pene-
tration level reached compared with the experiments without soap, is 
of the same order (2 x) as in other experiments (Bettley, 1961, 1963, 
1965; Polano, 1968). 
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SAMENVATTING 
In dit proefschrift worden de resultaten weergegeven van een onder-
zoek dat als voornaamste doel had informatie te verschaffen omtrent 
de resorptiesnelheid van naftol door de huid. Tevens had het onder-
zoek tot doel gegevens te verzamelen over de distributie, biotrans-
formatie en excretie van dit geneesmiddel. 
Er wordt een gas-chromatografische methode beschreven om naftol 
en zijn metabolieten te bepalen in plasma en urine. 
Plasmaspiegels van naftol en geconjugeerd naftol zijn gemeten tijdens 
en na de applicatie van een 20% naftol bevattende zalf - schilpasta -
gedurende de behandeling van patiënten met therapie resistente acne. 
Direct na de applicatie van de schilpasta is er een sterke stijging in de 
plasma geconjugeerd naftol concentratie. De niet geconjugeerde naftol-
concentratie blijft echter laag. De uitscheiding van vrij en geconjugeerd 
naftol met de urine wisselt sterk, zowel bij de patiënten onderling als 
bij één patiënt. De verkregen gegevens tonen aan dat de stof zeer 
snel via de huid geresorbeerd wordt. Naast conjugatie blijkt excretie 
via de nier de belangrijkste wijze van eliminatie te zijn. Bij de be-
handeling van relatief grote oppervlakken zal de concentratie van on-
geconjugeerd naftol in de tubuli van de nier zodanig stijgen dat een 
nierbeschadiging mogelijk is. 
Om een inzicht te krijgen in de pharmacokinetiek van naftol zijn de 
plasmaspiegels en urinegehaltes bepaald gedurende en na intrave-
neuse infusies bij honden. De plasmaspiegel wordt beschreven met 
behulp van een twee compartimenten open model. In dit model is 
het plasma een onderdeel van het centrale compartiment, dat in even-
wicht is met een perifeer compartiment. Evenals bij de mens wordt 
ook bij de hond gedurende een lange tijd geconjugeerd naftol in het 
plasma gevonden. 
De resorptiesnelheid van naftol door de huid is na applicatie op de 
flanken van de hond gemeten als functie van de tijd, om de invloed 
van de naftolconcentratie in de zalf en de samenstelling van de zalf te 
meten. 
Een toenemende concentratie van de naftol in de zalf geeft een stijging 
in de resorptiesnelheid te zien. Deze stijging bereikt bij ongeveer 5% 
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naftol een maximum Toevoeging van zeep aan de zalfbasis geeft een 
plateau dat ongeveer twee maal zo hoog ligt Voor de huid is de per-
meabiliteits-"constante" van de naftol in de verschillende zalven af-
hankelijk van de concentratie van de naftol. BIJ hogere naftolcon-
centratie is de permeabiliteits-"constante" kleiner 
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